Dr. Bojana Beleslin Čokić is a clinical biochemist and clinical geneticist with extensive experience in molecular diagnostics and genomics. She graduated from the University of Belgrade School of Medicine in 1996, earned her Master’s in Pharmacology in 2004, and her PhD on “Pseudohypoxic Pathways in Renal Tumors” in 2015. She completed specializations in Clinical Biochemistry (2012) and Clinical Genetics (2018). Her research experience includes training at the NIH (USA) and participation in European and national projects on stress adaptation, hematologic malignancies, pharmacogenetics, and viral infections. During the COVID-19 pandemic, she contributed to molecular diagnostics of SARS-CoV-2 and currently works on viral genomics and sequencing at the Institute “Torlak.” Her research interests include molecular biology and diagnostics, viral genomics (SARS-CoV-2, RSV, influenza), tumor biology, host-pathogen interactions, and microbiome studies. She is committed to translational research, integrating laboratory discoveries with clinical applications, and mentoring scientists.
Dr. Bojana Beleslin Čokić is a clinical biochemist and clinical geneticist with extensive experience in molecular diagnostics and genomics. She graduated from the University of Belgrade School of Medicine in 1996, earned her Master’s in Pharmacology in 2004, and her PhD on “Pseudohypoxic Pathways in Renal Tumors” in 2015. She completed specializations in Clinical Biochemistry (2012) and Clinical Genetics (2018). Her research experience includes training at the NIH (USA) and participation in European and national projects on stress adaptation, hematologic malignancies, pharmacogenetics, and viral infections. During the COVID-19 pandemic, she contributed to molecular diagnostics of SARS-CoV-2 and currently works on viral genomics and sequencing at the Institute “Torlak.” Her research interests include molecular biology and diagnostics, viral genomics (SARS-CoV-2, RSV, influenza), tumor biology, host-pathogen interactions, and microbiome studies. She is committed to translational research, integrating laboratory discoveries with clinical applications, and mentoring scientists.